By G HossainPosted on April 1, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs While peptides are currently the dominant approach to GLP-1 agonism, Ambrosia Biosciences is pursuing a small-molecule approach. Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B Post navigation IO Shuts Down Following Regulatory RoadblocksBiopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes